Fonte: Blood. Nome do evento: Annual Meeting of the American Society of Hematology. Unidade: FM
Assunto: HEMATOLOGIA
ABNT
MASSUMOTO, C M et al. Busulfan (bu) + melphalan (mel) as a preparative regimen for autologous bone marrow transplantation , the potential role in outpatient (opd) basis. Blood. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 1995APA
Massumoto, C. M., Ostronoff, M., Macedo, M. C. M. A., Zambon, E., Medeiros, R. S., Chamone, D. de A. F., et al. (1995). Busulfan (bu) + melphalan (mel) as a preparative regimen for autologous bone marrow transplantation , the potential role in outpatient (opd) basis. Blood. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Massumoto CM, Ostronoff M, Macedo MCMA, Zambon E, Medeiros RS, Chamone D de AF, Llacer PED, Dulley FL. Busulfan (bu) + melphalan (mel) as a preparative regimen for autologous bone marrow transplantation , the potential role in outpatient (opd) basis. Blood. 1995 ; no 1995( 10 suppl.1): 957a.[citado 2024 nov. 04 ]Vancouver
Massumoto CM, Ostronoff M, Macedo MCMA, Zambon E, Medeiros RS, Chamone D de AF, Llacer PED, Dulley FL. Busulfan (bu) + melphalan (mel) as a preparative regimen for autologous bone marrow transplantation , the potential role in outpatient (opd) basis. Blood. 1995 ; no 1995( 10 suppl.1): 957a.[citado 2024 nov. 04 ]